Skip to main content
. 2022 Nov 15;108(1):101–106. doi: 10.4269/ajtmh.22-0106

Table 4.

Scenario analysis: nitmatrelvir–ritonavir treatment, inputs, and results

Nitmatrelvir–ritonavir SOC Savings*
Cost category
 Emergency department $0.18 $8.22 –$8.04
 Hospitalization $77.32 $854 $776.77
 Drug costs $0.00 $529.00 –$710.00
 ICU utilization $406.51 –$369.71 $97.94
 Total costs $643.30 $1,268.82 –$625.52
Resource use
 Regular admission days 0.03 0.38 −0.35
 ICU days 0.04 0.44 −0.40
 Total hospital days 0.07 0.82 0.74

ICU = intensive care unit; SOC = standard of care.

*

A negative value indicates cost-additive result.